Table 1

The plating efficiency of expanded cells following ex vivo culture with HDACIs

Additions to culturesBFU-ECFU-MixCFU-GMPlating efficiency
None* 27.1 ± 4.5 4.6 ± 1.5 46.3 ± 12.0 16.0 ± 1.6 
Cytokines alone 9.8 ± 2.9 2.8 ± 1.6 29.6 ± 8.0 8.6 ± 1.3 
Cytokines + SAHA 19.2 ± 4.6 6.7 ± 2.5 42.1 ± 8.1 13.1 ± 3.0 
Cytokines + VPA 23.1 ± 3.2 8.0 ± 2.5 45.8 ± 6.4 14.9 ± 2.4 
Cytokines + TSA 18.1 ± 5.9 6.9 ± 2.7 43.3 ± 5.9 13.0 ± 1.7 
Additions to culturesBFU-ECFU-MixCFU-GMPlating efficiency
None* 27.1 ± 4.5 4.6 ± 1.5 46.3 ± 12.0 16.0 ± 1.6 
Cytokines alone 9.8 ± 2.9 2.8 ± 1.6 29.6 ± 8.0 8.6 ± 1.3 
Cytokines + SAHA 19.2 ± 4.6 6.7 ± 2.5 42.1 ± 8.1 13.1 ± 3.0 
Cytokines + VPA 23.1 ± 3.2 8.0 ± 2.5 45.8 ± 6.4 14.9 ± 2.4 
Cytokines + TSA 18.1 ± 5.9 6.9 ± 2.7 43.3 ± 5.9 13.0 ± 1.7 

Effects of HDACI treatment on plating efficiency of cells following ex vivo culture. CB CD34+ cells (day 0) or the cells cultured either in the presence or absence of HDACIs for 7 days were assayed for HPC.

BFU-E indicates burst-forming unit-erythroid; CFU-Mix, CFU granulocyte, erythroid, monocyte, and megakaryocyte; HPC, hematopoietic progenitor cell; and CFU-GM, CFU–granulocyte macrophage.

*

Identifies the behavior of the primary CB-CD34+ cells. Five hundred cells were plated in duplicate and each value represents the mean ± SD of 5 independent experiments. The plating efficiency is determined as: (BFU-E + CFU-mix + CFU-GM/number of cells plated) × 100.

The plating efficiency of the cells cultured in the presence of cytokines + VPA was statistically greater than that of the cells cultured with CA (P = 0.003, n = 5).

or Create an Account

Close Modal
Close Modal